Jesse Richman, MD is a board certified ophthalmologist who specializes in the surgical and medical treatment of glaucoma and cataracts.

Dr. Richman obtained his undergraduate pre-medical education at Penn State University in State College, PA, graduating cum laude. He then enrolled at Jefferson Medical College, where he earned his medical degree. After performing his transitional internship at Frankford Torresdale Hospital in Philadelphia, Pennsylvania, Dr. Richman completed a three-year residency in Ophthalmology at Brown University in Providence, RI, where he was awarded the William Tsiaras Research Award and was appointed Chief Resident of Ophthalmology. He then completed a Glaucoma Fellowship at Wills Eye Hospital. Dr. Richman continues to lecture and teach glaucoma to the residents at Wills Eye.

Dr. Richman has published numerous articles in peer-reviewed journals and authored chapters in ophthalmic textbooks. He has presented his top-notch research at several major ophthalmic assemblies including the American Glaucoma Society, the World Glaucoma Conference, the American Academy of Ophthalmology, the American Society of Ophthalmic Plastic & Reconstructive Surgery, and the Association for Research in Vision and Ophthalmology.

In addition, Dr. Richman, has patented a novel diagnostic test for the detection and management of glaucoma, named the Spaeth-Richman Contrast Sensitivity Test. He was the first ophthalmologist to implant the iStent trabecular micro bypass in the state of Delaware and has designed a single-step toric marker to aid in the reduction of astigmatism at the time of cataract surgery. Dr. Richman is a member of the American Academy of Ophthalmology and American Glaucoma Society.